Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study

Ilteris Oguz Topal,Sevim Baysak,İlknur Kıvanç Altunay,Asude Kara Polat,Eylem Emel Arıkan,Ezgi Özkur,Sema Aytekin,Bilal Dogan,Tuğba Özkök Akbulut,Filiz Topaloğlu Demir,Ayşe Serap Karadağ

Anais Brasileiros de Dermatologia（2022）

Cited 2|Views16

No score

Abstract

These findings suggest that secukinumab therapy is reasonably effective in patients with moderate-to-severe psoriasis. Comorbidities and time length of the disease can affect the response to treatment. The rates of adverse events were high in this patient population.

Translated text

Key words

Efficacy,Psoriasis,Safety

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined